A new impulsive noise removal filter, adaptive dynamically weighted median filter (ADWMF), is proposed. A popular method for removing impulsive noise is a median filter whereas the weighted median filter and c...
http://ift.tt/2yb8ObS
Αρχειοθήκη ιστολογίου
-
▼
2023
(138)
-
▼
Φεβρουαρίου
(74)
-
▼
Φεβ 19
(9)
- Multifunctional Two-Dimensional Bi2Se3 Nanodiscs f...
- Downregulation of miR‐193a/b‐3p during HPV‐induced...
- The ability of magnetic resonance imaging to predi...
- Frequent EGFR exon 20 insertion in the so‐called p...
- Central odontogenic fibroma with amyloid: a diagno...
- Tixagevimab/Cilgavimab Treatment and Cardiovascula...
- The Ixodes ricinus salivary gland proteome during ...
- Characterization of protein-based risk signature t...
- Acute Posterior Multifocal Placoid Pigment Epithel...
-
▼
Φεβ 19
(9)
- ► Ιανουαρίου (64)
-
▼
Φεβρουαρίου
(74)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
Αναζήτηση αυτού του ιστολογίου
Τρίτη 19 Σεπτεμβρίου 2017
An adaptive dynamically weighted median filter for impulse noise removal
Inclusion of pregnant and breastfeeding women in research – Efforts and Initiatives
ABSTRACT
Pregnant and breastfeeding women have been rendered therapeutic orphans as they have been historically excluded from clinical trials. Labeling for most approved drugs does not provide information about safety and efficacy during pregnancy. This lack of data is mainly due to ethico-legal challenges that have remained entrenched in the post-diethylstilbestrol and thalidomide era, and that have led to pregnancy being viewed in the clinical trial setting primarily through a pharmacovigilance lens. Policy considerations that encourage and/or require the inclusion of pregnant or lactating women in clinical trials may address the current lack of available information. However, there are additional pragmatic strategies, such the employment of pharmacometric tools and the introduction of innovative clinical trial designs, which could improve knowledge about the safety and efficacy of medication use during pregnancy and lactation. This paper provides a broad overview of the pharmacoepidemiology of drugs used during pregnancy and lactation, and offers recommendations for regulators and researchers in academia and industry to increase the available pharmacokinetic and –dynamic understanding of medication use in pregnancy.
http://ift.tt/2wsPwm3
Δευτέρα 18 Σεπτεμβρίου 2017
The impact of delayed maternity on foetal growth in Spain: An assessment by population attributable fraction
Publication date: Available online 18 September 2017
Source:Women and Birth
Author(s): Carlos Varea, José Manuel Terán, Cristina Bernis, Barry Bogin
BackgroundDelayed childbearing is considered a risk factor for maternal–foetal health. As in other higher-income countries, in Spain age at maternity has steadily increased during the last two decades.AimTo quantify the impact of the delay in the age at maternity on small for gestational age (SGA) categories of <3rd, 3rd–5th and 5th–10th percentiles.Methods2,672,350 singleton live births born to Spanish mothers in 2007–2015 were analysed. Adjusted relative risk was calculated to estimate the adjusted partial population attributable fractions (PAFp) for mothers aged 35–39 and ≥40 years for each category of SGA considering the interaction between age at maternity and parity.FindingsPrimipara 35–39 years old mothers have the highest PAFp in the three categories of SGA, with the maximum value for SGA <3rd percentile (2.57%, 95% CI 2.25, 2.88). PAFp for both primipara and multipara ≥40 years old mothers were less than 1%. PAFp for primipara older mothers increased significantly in 2007–2015 for the three categories of SGA, more clearly among those aged 35–39 years. The contribution of multipara mothers of both age groups did not increase significantly during the period.ConclusionDelayed maternity is a significant adjusted risk factor for SGA, contributing to the increase of its prevalence. However, results also suggest a limited clinical impact of delayed maternity on foetal growth. Positive changes in maternal profile associated with the shift in maternal age might contribute to explain the limited impact of mothers aged 35 years and older on negative birth outcome in Spain.
http://ift.tt/2wrSp6r
Advances in delivery of ambulatory autologous stem cell transplantation for multiple myeloma.
http://ift.tt/2xtDPul
The role of vitamin D in cancer cachexia.
http://ift.tt/2ffaYDu
Population-based models of planning for palliative care in older people.
http://ift.tt/2xuiqBz
Health professionals' quality of life in relation to end of life care.
http://ift.tt/2xtDO9L
-
Doctors are exposed to high levels of stress in the course of their profession and are particularly susceptible to experiencing burnout. Bur...
-
Objectives: To examine the performance of the urinary biomarker panel tissue inhibitor of metalloproteinase-2 and insulin-like growth fact...
-
Abstract We examined how maternal care within the bedtime and nighttime contexts influences infant cortisol levels and patterning. Eig...